DULUTH HOLDINGS INC - CL B (DLTH)

US26443V1017 - Common Stock

4.29  0 (0%)

Fundamental Rating

2

DLTH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 126 industry peers in the Specialty Retail industry. DLTH has a bad profitability rating. Also its financial health evaluation is rather negative. DLTH has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

In the past year DLTH has reported negative net income.
In the past year DLTH had a positive cash flow from operations.
DLTH had positive earnings in 4 of the past 5 years.
DLTH had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of DLTH (-1.91%) is comparable to the rest of the industry.
DLTH has a Return On Equity (-4.17%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.91%
ROE -4.17%
ROIC N/A
ROA(3y)1.43%
ROA(5y)2.18%
ROE(3y)3.33%
ROE(5y)5.52%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

DLTH has a better Gross Margin (50.26%) than 78.57% of its industry peers.
DLTH's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for DLTH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.07%
GM growth 5Y-1.66%

3

2. Health

2.1 Basic Checks

DLTH does not have a ROIC to compare to the WACC, probably because it is not profitable.
DLTH has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DLTH has been increased compared to 5 years ago.
The debt/assets ratio for DLTH is higher compared to a year ago.

2.2 Solvency

DLTH has an Altman-Z score of 2.14. This is not the best score and indicates that DLTH is in the grey zone with still only limited risk for bankruptcy at the moment.
DLTH has a Altman-Z score (2.14) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.26 indicates that DLTH is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.26, DLTH perfoms like the industry average, outperforming 59.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 2.14
ROIC/WACCN/A
WACC8.57%

2.3 Liquidity

DLTH has a Current Ratio of 1.77. This is a normal value and indicates that DLTH is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DLTH (1.77) is better than 67.46% of its industry peers.
A Quick Ratio of 0.54 indicates that DLTH may have some problems paying its short term obligations.
With a Quick ratio value of 0.54, DLTH perfoms like the industry average, outperforming 43.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 0.54

3

3. Growth

3.1 Past

The earnings per share for DLTH have decreased strongly by -514.29% in the last year.
The Revenue has decreased by -1.01% in the past year.
DLTH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.62% yearly.
EPS 1Y (TTM)-514.29%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-8.7%
Revenue 1Y (TTM)-1.01%
Revenue growth 3Y0.41%
Revenue growth 5Y2.62%
Revenue growth Q2Q1.58%

3.2 Future

DLTH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.62% yearly.
DLTH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.58% yearly.
EPS Next Y24.38%
EPS Next 2Y25.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.14%
Revenue Next 2Y0.58%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DLTH. In the last year negative earnings were reported.
Also next year DLTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

DLTH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DLTH is cheaper than 68.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.64

4.3 Compensation for Growth

A more expensive valuation may be justified as DLTH's earnings are expected to grow with 25.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.62%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DLTH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DULUTH HOLDINGS INC - CL B

NASDAQ:DLTH (4/25/2024, 10:13:02 AM)

4.29

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap147.62M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.91%
ROE -4.17%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 50.26%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.77
Quick Ratio 0.54
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-514.29%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y24.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.01%
Revenue growth 3Y0.41%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y